Fexofenadine hydrochloride has a good safety profile in treating allergic rhinitis in children 6-24 months of age, researchers report in the December issue of the Annals of Allergy, Asthma, and Immunology. Reuters Health Information
Targeted immunomodulating monoclonal antibodies are believed to cause fewer infectious sequelae than standard cytotoxic therapies for hematologic malignancies. The specific infections related to these new cancer therapeutics are reviewed. Journal of the National Comprehensive Cancer Network
Common variable immunodeficiency (CVID) encompasses a group of genetic disorders that is characterised by hypogammaglobulinemia, increased suceptability to infections and a variety of sequelae. Expert Review of Clinical Immunology
